$Treatment of refractory chronic graft-versus-host disease after allogeneic hematopoietic stem cell transplantation with low-dose interleukin-2$

Treatment of refractory chronic graft-versus-host disease after allogeneic hematopoietic stem cell transplantation with low-dose interleukin-2

Refractory chronic graft-versus-host disease (cGVHD) is the complication of allogeneic hematopoietic stem cell transplantation (HCT) that signi ficantly impacts quality of life, may be associated with morbidity and mortality and has limited treatment options. 16 adult pts (median age 22, range 16 -...

Full description

Saved in:

Bibliographic Details
Main Authors:	I. S. Moiseev, E. A. Burmina, Y. A. Tarakanova, Y. R. Zalyalov, A. G. Smirnova, O. V. Pirogova, S. N. Bondarenko, B. V. Afanasyev
Format:	Article
Language:	Russian
Published:	Academician I.P. Pavlov First St. Petersburg State Medical University 2015-12-01
Series:	Учёные записки Санкт-Петербургского государственного медицинского университета им. Акад. И.П. Павлова
Subjects:	аллогенная тгск хроническая реакция «трансплантат против хозяина» облитерирующий бронхиолит интерелейкин-2 allogeneic hsct chronic graft-versus-host disease bronchiolitis obliterans interleukin-2
Online Access:	https://www.sci-notes.ru/jour/article/view/151
Tags:	Add Tag No Tags, Be the first to tag this record!

Be the first to leave a comment!

Treatment of refractory chronic graft-versus-host disease after allogeneic hematopoietic stem cell transplantation with low-dose interleukin-2

Similar Items